Modelling and determination of the transmission contact rate for contagious bovine pleuropneumonia by Balenghien, Thomas et al.
Modelling and determination of the transmission contact rate
for contagious bovine pleuropneumonia
T. BALENGHIEN*, K. CHALVET-MONFRAY, D. J. BICOUT* AND P. SABATIER
Unite´ de Biomathe´matiques et Epide´miologie, INRA-Ecole Nationale Ve´te´rinaire de Lyon, 1 avenue Bourgelat,
B.P. 83, 69280 Marcy l’Etoile, France
(Accepted 18 November 2004)
SUMMARY
Contagious bovine pleuropneumonia (CBPP) is a cattle respiratory disease that represents one of
the major threats to cattle health and production in sub-Saharan Africa. The transmission
contact rate of CBPP plays a key role in the spreading dynamics of the disease. We have
developed an approach based on the combination of a SEIR model describing the spread of
CBPP with the dynamic of seroconversion to determine the transmission contact rate for CBPP.
This method has been subsequently applied to serological diagnostic data obtained from an
experimental vaccine trial. As a result, we ﬁnd that the transmission contact rates for subclinical,
clinical and chronic infective states are respectively, 0.084/N, 0.45 and 0.14/N per animal per day,
where N is the herd population size, and the basic reproductive number corresponding to this
trial (N=28) is R0=27.
INTRODUCTION
Contagious bovine pleuropneumonia (CBPP) is a
respiratory disease caused by Mycoplasma mycoides
subsp. mycoides Small Colony, designated MmmSC
[1]. It is a disease classiﬁed in the A list of the World
Organisation for Animal Health (ex. OIE) as causing
cattle mortality and loss of production along with
high costs for controlling [2]. Although CBPP out-
breaks occur regularly in Europe, CBPP remains one
of the major threats to cattle health and production in
Africa. The cessation of pan-African campaigns of
mass vaccination (PARC programme) has led to the
re-emergence of the disease in sub-Saharan Africa [3].
CBPP is mainly transmitted through expectorations
of coughing animals and secondarily through direct
contact [4]. As well as being contagious for the
duration of the incubation period, which is still
debated, freshly infected animals also become con-
tagious well before the onset of symptoms [5]. The
clinical patterns are extremely varied, from asympto-
matic to hyperacute forms. During the acute phase,
which is the most contagious stage, animals undergo
an increase of temperature, anorexia and respiratory
diﬃculties, sometimes until death, and present lesions
of severe ﬁbrinous pneumonia with pleural exudate.
Survivors of acute CBPP evolve to the chronic stage
that is often asymptomatic. It is assumed that the
chronic form is responsible for the disease persistence
[6], but to an extent which is still unknown [7].
Moreover, some animals may have developed natural
resistance to the disease.
In this paper, we address the issue of the trans-
mission contact rate (b), a parameter that plays a key
role in the spreading dynamics of the disease since it
measures the capability that an infective animal has
of transmitting the disease to others. All outputs of
models used in the control strategies of the disease
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and in cost–beneﬁt studies are very dependent upon
how the disease is spread, and thus, on the trans-
mission contact rate. Unfortunately, estimated values
of b for CBPP are still lacking in the literature. For
this purpose, we have developed an approach based
on the combination of a SEIR model describing the
spread of the disease with the dynamic of sero-
conversion to determine the transmission contact
rate of CBPP. Indeed, rather than directly following
the spread dynamics of a disease, which may prove
to be an onerous (if not impossible) task even in ex-
perimental trials, serological diagnostics is becoming
a widely used alternative technique for timing the
disease propagation in a given sample of the popu-
lation. In the form of a feedback loop, our approach
uses such a kind of serological diagnostic data to
assess the value of b that in turn controls the propa-
gation of the disease following the SEIR picture.
We have subsequently applied this method to sero-
logical data obtained from an experimental vaccine
trial to determine the transmission contact rate of
CBPP in experimental conditions.
METHODS
Description of mathematical models
The within-herd spread of CBPP is described using
the classical SEIR model where S, E, I and R rep-
resent the number of susceptible, latently infected,
infective and recovered animals respectively [8]. In
our model (Fig. 1), the infective class is, according to
the epidemiology of CBPP, subdivided into three
states: Is, Icl and Ich, where Is denotes the number of
early infective animals at the end of the incubation
period (subclinical), Icl the infective animals with
clinical symptoms (cough) and Ich the infective ani-
mals in the chronic state [9]. Each of these infective
states has a diﬀerent infectiousness represented by a
constant transmission contact rate, bi. The time evol-
ution of CBPP infection within a herd is described by
the following system of equations:
dS
dt
=xlS=x(bIcl Icl+bIs Is+bIch Ich)S
dE
dt
=lSxnE
dIs
dt
=nEx(a1+a2+a3)Is
dIcl
dt
=a1Isx(v+m)Icl
dIch
dt
=a2Is+vIclxcIch
dR
dt
=a3Is+cIch
9>>>>>>>>>>>=
>>>>>>>>>>>;
(1)
where l(t) is the force of infection, i.e. the fraction of
susceptible population that the infective animals are
able to enter in contact with and infect per unit of
time; the other parameters are deﬁned in the Table.
In writing the system of equation (1), we have ne-
glected the natural births and deaths and considered
only the disease-induced mortality such that the total
number of animals in the herd,
N(t)=S(t)+E(t)+Is(t)+Icl(t)+Ich(t)+R(t)
decays as, dN/dt=xmIcl.
In practice, except for clinical animals, a clear-cut
distinction between SEIR states as described above
is diﬃcult, if not impossible. On the contrary, sero-
logical diagnostics is a widely used technique to
identify animals that have been infected by patho-
gens. In this respect, it is very useful for practical
purposes to complement the above equations with
the dynamics of seroconversion. Animals newly con-
taminated by MmmSC become seropositive after a
time, T1, required for the synthesizing of antibodies.
In the absence of additional infectious contacts, a
seropositive animal will lose antibodies and become
seronegative beyond an elapsed time, T2, several
months after the onset of antibodies. We consider,
for simplicity, the case where the serological test is
perfect (i.e. the sensitivity and speciﬁcity level is
100%) and denote by Ax the number of animals
that are newly infected but still free of antibodies
(i.e. those entering the E compartment of SEIR as
described above) and denote by A+ the number of
animals that have seroconverted (i.e. carrying anti-
bodies). The dynamics of seroconversion can be
S E Is Ich
Icl
R
β ν γ
ω
µ
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3α
Fig. 1. Kinetic scheme of the within-herd compartmental
model for CBPP.
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described as:
dAx
dt
=l(t)S(t)xl(txT1)S(txT1)
dA+
dt
=l(txT1)S(txT1)
xl(txT1xT2)S(txT1xT2)
9>>>=
>>>;
(2)
with l(t)=0 for tf0. Note that these equations can
also be used for IgM or IgG antibodies with corre-
sponding T1 and T2. It is clear from equation (2) that
the dynamics of seroconversion is related to the
transmission contact rates through the force of infec-
tion, thus providing a useful way to determine the
rate of b. These transmission contact rates play a key
role in the spreading dynamics of the disease. Indeed,
following the introduction of a single infectious ani-
mal into a herd entirely constituted of susceptible
animals, CBPP will only spread if the basic repro-
ductive number, R0, is greater than 1, i.e. R0>1,
where:
R0=
bIsN0
a
+
a1
a
bIclN0
(m+v)
+
a1
a
v
(m+v)
bIchN0
c
+
a2
a
bIchN0
c
,
(3)
with a=a1+a2+a3. By deﬁnition, R0 is the mean
number of secondary cases generated by one primary
case in a naive population. Thus, the disease will die
out for R0f1. The expression of R0 given in equation
(3), that can also be derived using the next generation
method [12], is the summation of three terms each
representing the number of secondary cases generated
by subclinical, clinical and chronic infective animals
respectively. All these numbers of secondary cases are
proportional to their respective b’s.
Model of the transmission contact rate
The transmission contact rate, b, is the probability
per unit of time that an infectious animal will have
contact with and successfully transmit infection to a
susceptible animal. It is a bi-individual rate (i.e. in-
volves two individuals) that captures the aetiology
of the infectious process and combines a number of
epidemiological and environmental factors that aﬀect
the disease transmission. Under the homogeneous
mixing hypothesis, the transmission contact rate, bi,
of CBPP by an animal in one of the three infectious
states can be factorized as bi=aisibi, where ai is
related to the titre level of MmmSC in the animal’s
respiratory system, si is the contact rate between an
infective and a susceptible animal, and bi the trans-
mission probability in an established contact. As
CBPP can be transmitted either indirectly through
Table. Numerical values of the parameters of the model
Deﬁnitions Symbol Value Unit Reference
Latent rate n 0.0714 1/day [5]
Transmission contact rate of clinic b0 0.45 (0.42–0.46)
a 1/animal/day
Scaling factor of the contact rate s0 0.91 (0.83–1)
a
Transition rate
Subclinical to clinical a1 0.0184 1/day [4, 10]
Subclinical to chronic a2 0.0422 1/day [4, 10]
Subclinical to recovered a3 0.0107 1/day [4, 10]
Clinical to chronic v 0.0219 1/day [10, 11]
Per capita mortality rate m 0.0257 1/day [10, 11]
Recovery rate c 0.0083b 1/day
Mortality and morbidity
Deaths

13.8c %
13.7d
Cumulative clinical incidence

25.5c %
25.7d
Cumulative chronic incidence

71.2c %
71.3d
Time of appearance of antibodies T1 20¡4
a days
a Result from the best ﬁt to experimental data.
b See discussion in the text.
c Result from the experimental vaccine trial.
d Result from simulations.
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aerosol during animal coughing or through direct
contact, the contact rate function of clinical animals
(which cough) comprises two contributions, say,
sIcl=sa+sd (where sa and sd are the aerosol and
direct contact rates respectively) while that of sub-
clinical and chronic animals involve only sd. At the
scale of a herd, sd represents contributions to con-
tagion of the very local contacts while sa stands for
long-range contacts. It follows that bIs=aIssdbIs ,
bIcl=aIcl (sa+sd)bIcl and bIch=aIchsdbIch . It makes
sense to think that these b’s are not independent
of each other. In this respect, we set bIcl=b0, and as-
suming that transmission probabilities of MmmSC
are identical for all infectious states, i.e. bIs=bIcl=bIch ,
then bi can be written as follows: bi=aisibi.
bIs=
aIs
aIcl
sd
sd+sa
b0=
1
5
s0
N
b0
bIcl= aIcl (sa+sd)bIcl=b0
bIch=
aIch
aIcl
sd
sd+sa
b0=
3
8
s0
N
b0
9>>>=
>>>;
(4)
The ratios aIs=aIcl=1=5 and aIch=aIcl=3=8 have been
estimated from the mean titre of MmmSC in the ani-
mal respiratory system during an experimental study
of CBPP [5]. The ratios depend on the animal recep-
tivity to a given MmmSC strain. Next, we assume
that the transmission through the aerosol is density-
dependent, i.e. sa is constant such that the force of
infection due to aerosol contribution is proportional
to saIcl, and that the transmission through the direct
contact is frequency-dependent, i.e. sd / 1=N (where
N is the population size) in which the force of infec-
tion is a function of the proportion of infectivity,
namely sdI / I=N. The second equality in equation
(4) is obtained by setting sd/sa=s0/N and requiring
that s0/N<1. With these deﬁnitions, we have s0<N,
bIcl is independent of N but bIs and bIch are both de-
creasing functions of N. Now, according to the re-
lations in equation (4), the determination of three
transmission contact rates is reduced to determine b0
and s0, in for example, a vaccine trial.
Experimental data
For our purpose, we consider the experimental vac-
cine trial conducted in Australia by Hudson & Turner
[10] on 392 animals divided into 14 groups, each
comprising 28 animals. In each group, the trial con-
sisted of mixing nine non-vaccinated and 14 vacci-
nated animals with ﬁve experimentally infected and
symptomless animals, and following up the daily sero-
conversion of non-vaccinated animals employing a
complement ﬁxation test [13]. As a result, the authors
reported the daily proportion of seroconverted (IgM
antibodies) animals, of animals with clinical symp-
toms, the proportion of deaths, and of animals with
chronic lesions. The authors did not report either the
spread dynamics of the disease or the entire serologi-
cal dynamics, but only the day of the ﬁrst positive
serological reaction for each animal.
Determination of the transmission contact rate
In order to determine b0 and s0 from the data de-
scribed above, we ran simulations to mimic the situ-
ation of the vaccine trial. The program used for
numerical simulations was written in Fortran
language and compiled with Absoft Pro Fortran
8.01. Stochastic simulations are carried out following
a birth-and-death process where each possible tran-
sition event (infection, seroconversion, recovery,
death) occurs at random with rates given by the
deterministic equation (1). All stochastic trajectories
are run using the parameters given in the Table and
with the initial conditions (S, E, Is, Icl, Ich, R)=(9, 0,
5, 0, 0, 14), where S represents the non-vaccinated
animals, Is the infected ones, and the vaccinated ani-
mals are considered as recovered, i.e. R.
A x2 minimization procedure between the exper-
imental data and an average of 1000 stochastic simu-
lations has been used on the proportion of daily
seroconversion to determine T1 the onset time of
antibodies, b0 and s0. As a control, the simulated
deaths and cumulative incidence for clinical and
chronic animals are compared with observations of
the experimental trial in the Table. Next, 14 trajec-
tories (equivalent to 14 groups of the experimental
trial) using the parameters just determined have been
run to generate the curves in Figure 2.
RESULTS AND DISCUSSION
The best ﬁt to experimental data using the x2 minimiz-
ation procedure givesT1=20 days for the onset of anti-
bodies, s0=0.91 (0.83–1) and b0=0.45 (0.42–0.46),
corresponding to R0=26.5 (25.2–26.7) calculated
from equation (3) with N=S0=9. The transmission
contact rates for infective animals are : bIs=0·084=N,
bIcl=0·45 and bIch=0·014=N per animal per day,
where N is the time-dependent herd population
size. At the beginning of the experiment when
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N=28, we had ratios between bIcl=bIs=150 and
bIcl=bIch=90.
Simulated and experimental mortality and mor-
bidity are respectively, 13.7% and 13.8% for deaths,
25.7% and 25.5% for cumulative clinical incidence
and 71.3% and 71.2% for cumulative chronic inci-
dence (see Table).
Under the hypotheses that (i) all I classes are in-
fective with a given bi and (ii) bi’s are related to each
other as given in equation (4), we found that the trans-
mission contact rates of CBPP are approximately
10x3–10x1 per animal per day. However, it is worth-
while to underline that these determined values have
been obtained for experimental conditions that are
known to be challenging for infectious contacts with
a high degree of conﬁnement and highly virulent
strain of MmmSC. For instance, the mean number,
R0, of secondary cases generated by an infective
animal in this experimental condition is R0=27,
which is of the same order as the population size
N=28 of the trial. Thus, one expects that the trans-
mission rates found in ﬁeld and natural conditions be
approximately one- to twofold smaller than in exper-
imental conditions. As an illustrative comparison, the
transmission contact rate for tuberculosis (another
chronic respiratory disease) has been found to be
y10x5 per animal per day for a herd of a few hundred
animals in natural conditions [14, 15].
Values of transmission contact rates obtained
above are conditional to the duration of the chronic
state. The reason why chronic animals are considered
to be responsible for the persistence of the disease is
that active MmmSC can be found in the sequestra of
chronic animals during 27 months [7]. In our simu-
lations, we found that the spreading dynamics became
independent of the chronic state for durations of
>30 days (results not reported). Thus, consistent
with the literature [4, 6], we used a mean duration
of 120 days for the chronic state in all simulations.
We also found that not just the duration but the
presence of the chronic class is essential to correctly ﬁt
experimental data as the introduction of subclinical
animals generates chronic ones according to the
dynamic picture described earlier. When the chronic
state is removed from the spreading dynamics of the
disease, simulations failed to properly reproduce the
time evolution of seroconversion and the values of
transmission contact rates thus obtained are much
higher.
Nevertheless, it is worthwhile mentioning that the
same set of experimental data can be well ﬁtted even
with spreading dynamics models that do not incor-
porate the chronic class. Examples of such models
use a distribution of incubation periods for the E
class (Lesnoﬀ, M. personal communication). Hence,
diﬀerent patterns of the spreading dynamics of the
disease may also lead to identical dynamics of sero-
conversion. This emphasizes that more data on the
dynamics of the disease are required to test and
choose appropriate models.
Finally, it is already remarkable that the approach
outlined above is capable of reproducing a number of
features of an experimental trial. It will now be inter-
esting to use the same method on serological ﬁeld data
to determine the transmission contact rates of CBPP
in natural conditions, provided that the recovery rate
is known. However, the model can be embellished in
various directions, for instance, by simultaneously
using a diﬀerent functional form of b vs. N and
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Fig. 2. Experimental data [(a) black histograms, (b) symbols]
from Hudson & Turner [10] and simulated data [(a) white
histograms, (b) solid line] for a vaccine trial. Panel (a) shows
the incidence of weekly seroconversion and panel (b) the
cumulative daily seroconversion. The parameters used are
given in the Table, with b0=0.45 per animal per day,
s0=0.91 and T1=20 days.
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including the distribution of incubation times. Such a
work is underway.
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